UPDATE : Monday, September 7, 2020
상단여백
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker by Jeong Sae-im 2019-07-05 16:00
Lilly aims to reshape Korea’s breast cancer treatment market by Lee Han-soo 2019-07-05 16:00
‘Truvada will improve Korea's HIV treatment environment’ by Lee Han-soo 2019-07-04 10:53
Janssen nixes deal with Hanmi over antidiabetic obesity drug by Jeong Sae-im 2019-07-04 10:52
Bukwang, UK university to co-develop Parkinson’s disease treatment by Lee Han-soo 2019-07-03 15:03
라인
Handok releases Fabry disease treatment by Lee Han-soo 2019-07-02 16:19
26 new drugs approved in H1 by Lee Hye-seon 2019-07-02 14:31
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How? by Jeong Sae-im 2019-07-02 12:11
Huons launches new osteoarthritis treatment by Lee Han-soo 2019-07-01 15:13
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz by Lee Han-soo 2019-07-01 14:27
라인
BMS Korea files administrative suit to appeal Eliquis price cut by Kim Yun-mi 2019-07-01 14:16
Yuhan signs $870 million licensing deal with Boehringer Ingelheim by Lee Han-soo 2019-07-01 14:09
'Proteogenomics will improve ability to prevent, diagnose and treat cancer at molecular level' by Lee Han-soo 2019-06-28 17:43
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular by Kim Yun-mi 2019-06-28 16:12
Samsung Bioepis readies phase-3 trial on Soliris biosimilar by Lee Hye-seon 2019-06-27 17:14
라인
Eutilex unveils immunotherapy development strategy by Lee Han-soo 2019-06-27 16:51
Voluntary nullifications of drug license tripled in H1 by Lee Hye-seon 2019-06-26 14:25
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan by Lee Han-soo 2019-06-26 13:58
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia by Lee Han-soo 2019-06-26 11:39
Huons Global launches new BTX in Korea by Lee Han-soo 2019-06-26 10:52
여백
여백
여백
Back to Top